Showing results (491-500 of 565) with videos related to

Sort By:
Pageof 57
Nucleic Acids Research|January 20, 2023
Allosteric autoregulation of DNA binding via a DNA-mimicking protein domain: a biophysical study of ZNF410-DNA interaction using small angle X-ray scatteringGundeep Kaur, Ren Ren, Michal Hammel, et al.
Plos One|December 31, 2025
Phenology of nesting marine turtles in the Cayman IslandsLiliana P Colman, Jane L Hardwick, Timothy J Austin, et al.
Ecology|January 22, 2020
Nutrient addition increases grassland sensitivity to droughtsSiddharth Bharath, Elizabeth T Borer, Lori A Biederman, et al.
JAMA Network Open|June 7, 2021
Prevalence of Angina Among Primary Care Patients With Coronary Artery DiseaseDaniel M Blumenthal, Sidney E Howard, Jennifer Searl Como, et al.
The Journal of Allergy and Clinical Immunology|April 1, 1996
Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitisE A Bronsky, R J Dockhorn, E O Meltzer, et al.
JAMA Oncology|March 2, 2018
A 25-Year Experience of US Food and Drug Administration Accelerated Approval of Malignant Hematology and Oncology Drugs and Biologics: A ReviewJulia A Beaver, Lynn J Howie, Lorraine Pelosof, et al.
Disaster Medicine and Public Health Preparedness|March 13, 2014
Recovery and resilience after a nuclear power plant disaster: a medical decision model for managing an effective, timely, and balanced responseC Norman Coleman, Daniel J Blumenthal, Charles A Casto, et al.
JCO Clinical Cancer Informatics|July 23, 2021
Model Development of CDK4/6 Predicted Efficacy in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced or Metastatic Breast CancerJeremy Mason, Yutao Gong, Laleh Amiri-Kordestani, et al.
The Oncologist|February 12, 2020
FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host DiseaseDonna Przepiorka, Lola Luo, Sriram Subramaniam, et al.
The Oncologist|August 25, 2017
FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and BeyondLee Pai-Scherf, Gideon M Blumenthal, Hongshan Li, et al.
Pageof 57